Medically Reviewed by Dr. Susmita Aryal, MD, Written by Swati Pund, PhD
Menopause is a significant life stage that encompasses emotional, physiological, and physical transitions. From hot flashes and heart palpitations to mood swings and changes in sexual desire, many women experience a range of symptoms during this period. If you are experiencing such symptoms, you may want to discuss menopause hormone therapy (MHT) with your doctor. Research consistently shows that menopause hormone therapy is one of the most effective treatments for menopausal symptoms. This blog post provides an overview of menopause, the rationale behind menopause hormone therapy, and a detailed look at how different forms of menopause hormone replacement can address various symptoms.
The Mechanism of Menopause
Menopause is clinically defined as the absence of menstrual bleeding for 12 consecutive months. However, the transition—often called perimenopause—begins well before this point. Shifting hormone levels during perimenopause can cause noticeable changes in mood, sleep, skin, and other areas of health. The menopausal journey is highly individual, with symptoms varying significantly from person to person.
Research shows that symptoms are typically most severe during the first two years of menopause, after which they often recede slowly. However, every woman’s experience is unique, and the duration and intensity of symptoms can vary considerably. Recognising early signs and seeking appropriate treatment can help manage symptoms effectively.
During the menopausal transition, production of hormones such as estrogen and progesterone declines significantly. These hormonal changes underlie most menopausal symptoms. Tailoring menopause hormone therapy to an individual’s needs—using the right hormones in the right doses—can offer substantial relief.
MHT: The Basics
Menopause hormone therapy (MHT) is a primary treatment approach for many menopause-related symptoms. It involves supplementing hormones like estrogen, with or without progesterone, to compensate for the body’s declining hormone production. Although it may seem complex at first, understanding the basic options and how they work can help you and your doctor tailor an effective plan for symptom relief.
Estrogen Alone or in Combination
Menopause hormone therapy typically involves estrogen alone or estrogen combined with progesterone. Estrogen can be administered in various forms including oral tablets, skin patches, creams, gels, and sprays.
- Estrogen Alone: Often prescribed for women who have had a hysterectomy (uterus removal).
- Estrogen + Progesterone: In women with a uterus, progesterone is usually added to protect the uterine lining from excessive growth caused by estrogen.
Tissue-Selective Estrogen Complex
Another option includes a tissue-selective estrogen complex, where estrogen is combined with specific agents designed to target certain tissues selectively. Studies show this approach can be especially beneficial for hot flashes, joint pain, and vaginal dryness.
Common Menopausal Symptoms and Menopause Hormone Therapy
Below is an overview of key symptoms, why they happen, and how MHT may help.
1. Vasomotor Symptoms (Hot Flashes and Night Sweats)
Hot flashes and night sweats, together known as vasomotor symptoms, are often the most recognised indicators of menopause. They can range from mild warmth to intense heat surges accompanied by sweating.
- What They Are: Hot flashes typically last for some minutes, beginning with sudden sensations of heat, followed by sweating and chills.
- Why They Occur: Decreased estrogen can disrupt the body’s temperature regulation, causing rapid rises in body heat and subsequent sweating.
- How Menopause Hormone Therapy Helps:
- Estrogen Alone: Oral pills, skin patches, creams, sprays, or gels are effective for reducing hot flashes.
- Who Might Use It: Women without a uterus are commonly prescribed estrogen alone. Women with a uterus often take combined therapy.
Vasomotor symptoms can be unsettling and disruptive, but MHT has proven highly effective for many women in reducing their frequency and intensity.
2. Sleep Difficulties
Restful sleep is essential for emotional and physical well-being. Unfortunately, many women find it difficult to get uninterrupted sleep as they transition into menopause.
- What They Are: Difficulty falling or staying asleep, sometimes accompanied by restless legs or frequent awakenings.
- Prevalence: About 35–60% of women in menopause report sleep disorders.
- Why They Occur: Reproductive hormones play a crucial role in sleep induction through specific receptors in the brain. Their decline during menopause can significantly disrupt normal sleep patterns.
- How Menopause Hormone Therapy Helps:
- Estrogen + Progesterone: This combination may aid sleep and alleviate night sweats, which often disrupt sleep quality.
Improving sleep can dramatically enhance overall quality of life. Menopause hormone therapy may help address insomnia or disrupted sleep, offering a more rested and balanced daily routine.
3. Mood Swings or Low Moods
Emotional well-being can fluctuate significantly during menopause. Many women notice feelings of sadness, anxiety, or irritation during this transition.
- What They Are: Emotional fluctuations ranging from anxiety to depressive symptoms.
- Why They Occur: Hormonal shifts directly affect the brain’s chemical regulation system, impacting neurotransmitters responsible for mood regulation. Additionally, poor sleep can worsen mood issues.
- How Menopause Hormone Therapy Helps:
- Estrogen Alone or Combined: Can be beneficial for mood disturbances, though individual responses vary.
Stable mood is essential for navigating daily life. By addressing hormonal deficits, MHT can provide relief for some women dealing with depressive or anxious symptoms.
4. Aching Muscles and Joints
Joint stiffness and muscle pain can emerge or intensify around menopause, affecting mobility and exercise routines.
- What They Are: Approximately 70% of women experience muscle and joint-related problems during menopause. These issues can manifest as muscle cramps, joint stiffness, arthritis, and pain that can disrupt daily activities or workouts.
- Why They Occur: Lower estrogen levels increase inflammation and reduce bone mineral density, leading to musculoskeletal discomfort (arthritis).
- How Menopause Hormone Therapy Helps:
- Estrogen Therapy: Has shown benefits in reducing joint pain, and it may aid in preventing fractures and osteoporosis.
Painful muscles and joints need not derail your health goals. Estrogen therapy can help minimise discomfort and maintain bone health during and after the menopausal transition.
5. Migraines, Headaches, and Ear Disturbances
Headaches and migraines can worsen with menopause. Additionally, some women experience ringing in the ears or dizziness during this time.
- What They Are: Worsening of migraine attacks during menopause; some women also report ringing in the ears (tinnitus) or middle-ear disturbance (dizziness) as a result of the throbbing headaches.
- Why They Occur: Fluctuating estrogen levels can trigger migraines and possibly contribute to vestibular (inner ear) issues.
- How Menopause Hormone Therapy Helps:
- Estradiol Patches: Certain case studies suggest that estradiol patches may help reduce migraine attacks in menopausal women.
- Combined Menopause Hormone Therapy: Plant-based estrogen, with or without progesterone, may help alleviate dizziness.
If migraines or ear disturbances significantly impact your life, menopause hormone therapy can be a key component of a comprehensive strategy to reduce or manage these symptoms.
6. Urogenital Problems
Menopausal hormone changes can affect the urinary and genital tracts, leading to discomfort and recurrent infections.
- What They Are: Vaginal dryness, burning sensation during urination, and increased frequency of urinary infections.
- Why They Occur: Loss of estrogen leads to thinning and drying of the vaginal tissues, making them more prone to irritation.
- How MHT Helps:
- Localised Estrogen: Low-dose vaginal estrogen (creams, rings, or tablets) is considered a gold standard for urogenital symptoms.
- Alternative: Vaginal dehydroepiandrosterone (DHEA) can also be effective for vulvar atrophy.
Healthy urogenital function is critical to comfort and overall well-being. Localized estrogen therapies can offer targeted relief without necessarily affecting the entire body’s hormone levels.
7. Low Libido
A diminished interest in sexual activity can be distressing for many women during menopause, often linked with other menopausal symptoms like dryness or mood changes.
- What It Is: Decreased interest in sexual activity, often compounded by other menopausal issues such as mood changes and vaginal dryness.
- Why It Occurs: Declining hormones, discomfort during intercourse, and reduced well-being can all affect desire. Additional factors include sleep disturbances, overall low quality of life, and mood changes.
- How Menopause Hormone Therapy Helps:
- Estrogen Alone or Combined: May slightly increase sexual desire and help alleviate vaginal dryness, improving discomfort caused during intercourse.
Regaining comfort and confidence in your intimate life can significantly improve your relationships and self-esteem. Menopause hormone therapy may offer a supportive path toward renewed sexual vitality.
8. Skin and Hair Changes
Menopause can bring noticeable changes in the quality and appearance of skin and hair, often leading to dryness and a loss of elasticity.
- What They Are: Dry, thinning skin prone to wrinkles, and hair becoming dry or brittle. According to a review, some women also experience a sensation of “skin crawling,” known as formication.
- Why They Occur: Estrogen helps maintain skin elasticity and collagen; its decline leads to dryness, wrinkles, and sagging.
- How Menopause Hormone Therapy Helps:
- Estrogen Therapy: Can improve skin moisture, firmness, and collagen synthesis. Both Oral and Transdermal hormone therapy is beneficial in increasing collagen synthesis in the skin to retain a youthful look.
- Topical Applications: May further support skin integrity.
By maintaining hormone levels, you can help support healthier skin and hair. Combined with topical skincare routines, MHT may slow or reduce these visible signs of menopause.
9. Heart Palpitations
A sudden, racing heartbeat can be alarming, and for many women, it appears out of the blue during menopause.
- What They Are: A sensation of a racing or pounding heartbeat, which can be unsettling and often further increases anxiety levels.
- Prevalence: Between 20–50% of women in menopause experience palpitations.
- How Menopause Hormone Therapy Helps:
- Estradiol: Clinical studies suggest estradiol could reduce the frequency and severity of palpitations.
Managing palpitations can improve peace of mind and overall wellness. Consulting with a healthcare provider about menopause hormone therapy may help regulate these unsettling sensations.
Conclusion
MHT—whether estrogen alone or combined with progesterone—can be a key strategy in effectively managing menopausal symptoms. By replenishing dwindling hormone levels, MHT offers relief from hot flashes, sleep disturbances, mood swings, joint pain, urogenital issues, and more. As with any treatment, it is crucial to consult with a qualified healthcare provider to determine the best approach for your individual needs, taking into account your medical history and personal preferences.
References
1. Flores VA, Pal L, Manson JE. Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment. Endocrine reviews. 2021;42(6):720-52. https://doi.org/10.1210/endrev/bnab011
2. Paciuc J. Hormone Therapy in Menopause. Advances in experimental medicine and biology. 2020;1242:89-120. https://doi.org/10.1007/978-3-030-38474-6_6
3. Pan M, Zhou J, Pan X, Wang J, Qi Q, Wang L. Drugs for the treatment of postmenopausal symptoms: Hormonal and non-hormonal therapy. Life sciences. 2023;312:121255. https://doi.org/10.1016/j.lfs.2022.121255
4. Santoro N, Roeca C, Peters BA, Neal-Perry G. The Menopause Transition: Signs, Symptoms, and Management Options. The Journal of clinical endocrinology and metabolism. 2021;106(1):1-15. https://doi.org/10.1210/clinem/dgaa764
5. Lello S, Capozzi A, Scambia G. The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause. International journal of endocrinology. 2017;2017:5064725. https://doi.org/10.1155/2017/5064725
6. Cho L, Kaunitz AM, Faubion SS, Hayes SN, Lau ES, Pristera N, et al. Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long? Circulation. 2023;147(7):597-610. https://doi.org/10.1161/circulationaha.122.061559
7. Mehta J, Kling JM, Manson JE. Risks, Benefits, and Treatment Modalities of Menopausal Hormone Therapy: Current Concepts. Frontiers in endocrinology. 2021;12:564781. https://doi.org/10.3389/fendo.2021.564781
8. Tandon VR, Sharma S, Mahajan A, Mahajan A, Tandon A. Menopause and Sleep Disorders. Journal of mid-life health. 2022;13(1):26-33. https://doi.org/10.4103/jmh.jmh_18_22
9. Herson M, Kulkarni J. Hormonal Agents for the Treatment of Depression Associated with the Menopause. Drugs & aging. 2022;39(8):607-18. https://doi.org/10.1007/s40266-022-00962-x
10. Wright VJ, Schwartzman JD, Itinoche R, Wittstein J. The musculoskeletal syndrome of menopause. Climacteric : the journal of the International Menopause Society. 2024;27(5):466-72. https://doi.org/10.1080/13697137.2024.2380363
11. Pan M, Pan X, Zhou J, Wang J, Qi Q, Wang L. Update on hormone therapy for the management of postmenopausal women. Bioscience trends. 2022;16(1):46-57. https://doi.org/10.5582/bst.2021.01418
12. van Lohuizen R, Paungarttner J, Lampl C, MaassenVanDenBrink A, Al-Hassany L. Considerations for hormonal therapy in migraine patients: a critical review of current practice. Expert review of neurotherapeutics. 2023;24(1):1-21. https://doi.org/10.1080/14737175.2023.2296610
13. MacGregor EA, Briggs P. Hormone replacement therapy (HRT) in perimenopausal women with migraine. Post Reproductive Health. 2024;30(1):64-6. https://doi.org/10.1177/20533691241237110
14. Ma X, Lu YQ, Zhao YX, Yu LS, Bai WP, Lai RC, et al. [Preliminary analysis of risk factors of tinnitus related to female menopause]. Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery. 2024;59(9):916-21. https://doi.org/10.3760/cma.j.cn115330-20240107-00017
15. Castillo-Bustamante M, Çelebisoy N, Echavarria LG, Franco I, Valencia S, Gonzalez S, et al. Balance in Transition: Unraveling the Link Between Menopause and Vertigo. Cureus. 2024;16(4):e59277. https://doi.org/10.7759/cureus.59277
16. Benini V, Ruffolo AF, Casiraghi A, Degliuomini RS, Frigerio M, Braga A, et al. New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review. Medicina (Kaunas, Lithuania). 2022;58(6). https://doi.org/10.3390/medicina58060770
17. Lara LA, Cartagena-Ramos D, Figueiredo JB, Rosa ESACJ, Ferriani RA, Martins WP, et al. Hormone therapy for sexual function in perimenopausal and postmenopausal women. The Cochrane database of systematic reviews. 2023;8(8):Cd009672. https://doi.org/10.1002/14651858.CD009672.pub3
18. Rzepecki AK, Murase JE, Juran R, Fabi SG, McLellan BN. Estrogen-deficient skin: The role of topical therapy. International journal of women’s dermatology. 2019;5(2):85-90. https://doi.org/10.1016/j.ijwd.2019.01.001
19. Pivazyan L, Avetisyan J, Loshkareva M, Abdurakhmanova A. Skin Rejuvenation in Women using Menopausal Hormone Therapy: A Systematic Review and Meta-Analysis. Journal of menopausal medicine. 2023;29(3):97-111. https://doi.org/10.6118/jmm.22042
20. Fang Y, Liu F, Zhang X, Chen L, Liu Y, Yang L, et al. Mapping global prevalence of menopausal symptoms among middle-aged women: a systematic review and meta-analysis. BMC Public Health. 2024;24(1):1767. https://doi.org/10.1186/s12889-024-19280-5
21. Bravo B, Penedo L, Carvalho R, Dal Vesco C, Calomeni M, Gapanowicz D, et al. Dermatological Changes during Menopause and HRT: What to Expect? Cosmetics. 2024;11(1):9. https://doi.org/10.3390/cosmetics11010009
22. Sheng Y, Carpenter JS, Elomba CD, Alwine JS, Yue M, Chen CX, et al. Effect of menopausal symptom treatment options on palpitations: a systematic review. Climacteric : the journal of the International Menopause Society. 2022;25(2):128-40. https://doi.org/10.1080/13697137.2021.1948006